ICU Medical Q2 GAAP EPS $0.76, adjusted EPS $2.37; organic revenue up 6%

ICU MEDICAL INC/DE

GAAP revenue $551.7M (+1% YoY); non-GAAP organic revenue +6% excluding IV Solutions divestiture and FX.
GAAP net income $19.1M ($0.76 diluted EPS) vs $35.3M ($1.43) in Q2 2025.
Adjusted diluted EPS $2.37 vs $2.10; adjusted EBITDA $110.0M vs $100.3M.
GAAP gross margin improved to 43% from 38% YoY.
FY2026 guidance updated; specific numbers not available in provided excerpt.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.